Vanguard Asset Management’s CareDx CDNA Stock Holding History

Vanguard Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$947K	Hold	33,232	–	–	﹤0.01%	1901
2026 Q1	$577K	Buy	+33,232	New	+$629K	﹤0.01%	2031

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Vanguard Asset Management's CDNA Position: Q2 2026 in Review

Vanguard Asset Management held its CareDx (CDNA) position steady in Q2 2026 at 33,232 shares worth $947K. The position accounts for ﹤0.01% of the portfolio, ranked #1901.

Vanguard Asset Management first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 210 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Vanguard Asset Management held 33,232 shares of CareDx worth $947K as of Q2 2026.
Vanguard Asset Management left its CareDx share count unchanged in Q2 2026.
CareDx made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1901 holding.
Vanguard Asset Management first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
210 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.